BioSpace News Archive

Applied UV, Inc. (NASDAQ:AUVI) , an infection control technology company that applies the power of narrow-range ultraviolet light for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that the Company will host an investor conference call and live webcast to discuss its results on Wednesday March 31 2021

Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it will present at a virtual Fireside Chat hosted by Cantor Fitzgerald and Kristen Kluska, Biotechnology Analyst,

AIkido Pharma Inc. announced that it is sponsoring psychedelic research at the Mount Sinai Center for Psychedelic Psychotherapy and Trauma Research.

The U.S. Food and Drug Administration (FDA) has approved two Octapharma supplements to Biological License Applications, strengthening the company’s pediatric critical care product portfolio.

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced the publication of Phase I data in The Journal of ImmunoTherapy of Cancer (JITC).

Industry-wide, spreadsheets have long been the go-to method for tracking clinical trial start-up, but now a new purpose-built solution is available that has been created expressly to improve efficiency and quality in a clinical trial’s study start-up across the entire clinical development process.

Theralink Technologies, Inc., a precision medicine and molecular profiling company specializing in patented, biomarker assay services that target multiple areas of oncology, announced that the Company has received Clinical and Public Health License from the State of California for its Golden, Colorado laboratory, effective March 11th, 2021.

Fact.MR, Rockville MD: An ongoing study on the oral chemotherapy market by consulting firm Fact.MR anticipates a healthy growth outlook for FY 2021-22 and beyond, as global incidence of cancers across key regions increase at an alarming pace.

Cat allergy is an allergic reaction in humans to the allergens produced by cats. The most common cat allergen types are Fel d1 and Fel d4.

The hospitals have extensive activity region and size of activity when contrasted with walking focuses and crisis care focuses.